Heartflow (NASDAQ:HTFL) Shares Break Below 50-Day Moving Average – Time to Sell?

Heartflow, Inc. (NASDAQ:HTFL) shares crossed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $51.91 and traded as low as $48.27. Heartflow shares last traded at $48.46, with a volume of 3,705,135 shares.

Recent Heartflow Headlines

These are some of the HTFL headlines that stood out recently:

• Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.5 million consensus, signaling stronger expected growth. Financial results and guidance
• Positive Sentiment: Wells Fargo, Canaccord Genuity, Stifel and Baird raised their price targets to $68–$70 and maintained positive ratings, reflecting improved analyst expectations. Wells Fargo rating Canaccord Genuity rating Stifel rating Baird rating
• Negative Sentiment: A report said Heartflow’s CEO sold about $2.17 million worth of stock. Insider selling can concern investors, though the report alone does not establish the reason for the sale. CEO stock sale

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HTFL. Robert W. Baird lifted their price target on shares of Heartflow from $56.00 to $68.00 and gave the company an “outperform” rating in a research report on Friday. Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. JPMorgan Chase & Co. raised their target price on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Heartflow in a report on Wednesday, November 4th. Finally, Canaccord Genuity Group lifted their target price on shares of Heartflow from $56.00 to $69.00 and gave the company a “buy” rating in a report on Friday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $60.12.

Heartflow Stock Performance

The firm has a fifty day moving average of $51.91 and a 200 day moving average of $35.23. The firm has a market capitalization of $4.21 billion, a PE ratio of -52.67 and a beta of 2.50.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.42% and a negative net margin of 33.11%. The firm had revenue of $72.86 million during the quarter. During the same quarter in the prior year, the company earned ($0.27) EPS. Research analysts forecast that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Activity

In other Heartflow news, CFO Vikram Verghese sold 29,714 shares of the business’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84. Following the transaction, the chief financial officer owned 184,789 shares in the company, valued at $9,250,537.34. The trade was a 13.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 23,933 shares of the company’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33. Following the completion of the transaction, the insider directly owned 73,453 shares of the company’s stock, valued at approximately $4,040,649.53. The trade was a 24.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 332,403 shares of company stock worth $16,602,786. 7.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HTFL. XXEC Inc. bought a new stake in shares of Heartflow in the second quarter worth $2,524,764,000. BlackRock Inc. bought a new position in Heartflow during the 2nd quarter valued at $152,502,000. Bamco Inc. NY bought a new position in Heartflow during the 2nd quarter valued at $94,625,000. Jupiter Topco LLC acquired a new position in Heartflow during the 2nd quarter worth $70,983,000. Finally, Janus Henderson Group PLC grew its holdings in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after acquiring an additional 1,315,416 shares in the last quarter.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.